Bradley R

ORCID: 0000-0002-8073-3671 · 4 papers in corpus
nonrandomized-trial 2022
Safety and tolerability of Pau d' Arco (Tabebuia avellanedae) for primary dysmenorrhea: A single-arm, open-label trial on adults ages 18-45
Advances in integrative medicine ·doi:10.1016/j.aimed.2022.04.003

OBJECTIVES: To evaluate the safety and tolerability of encapsulated Tabebuia avellanedae in generally healthy women aged 18-45 with primary dysmenorrhea. METHODS: A single arm, open-label trial was conducted in which 1050 mg/day of encapsu…

nonrandomized-trial 2020
Early evidence of efficacy for orally administered SPM-enriched marine lipid fraction on quality of life and pain in a sample of adults with chronic pain
Journal of translational medicine ·doi:10.1186/s12967-020-02569-5

BACKGROUND: Marine lipids contain omega-3 fatty acids that can be metabolized into anti-inflammatory and pro-resolving mediators-namely 17-HDHA and 18-HEPE-which can serve as modulators of the pain experience. The purpose of this study was …

observational 2020
Overview of international naturopathic practice and patient characteristics: results from a cross-sectional study in 14 countries
BMC complementary medicine and therapies ·doi:10.1186/s12906-020-2851-7

BACKGROUND: Naturopathy is a distinct system of traditional and complementary medicine recognized by the World Health Organization and defined by its philosophic approach to patient care, rather than the treatments used by practitioners. Wo…

2017
World Congress Integrative Medicine & Health 2017: Part one : Berlin, Germany. 3-5 May 2017
BMC complementary and alternative medicine